1. Home
  2. ATXG vs TIVC Comparison

ATXG vs TIVC Comparison

Compare ATXG & TIVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATXG

Addentax Group Corp.

HOLD

Current Price

$4.27

Market Cap

4.1M

ML Signal

HOLD

Logo Tivic Health Systems Inc.

TIVC

Tivic Health Systems Inc.

HOLD

Current Price

$1.40

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATXG
TIVC
Founded
2014
2016
Country
China
United States
Employees
112
N/A
Industry
Professional Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
3.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ATXG
TIVC
Price
$4.27
$1.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
36.9K
260.7K
Earning Date
02-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$780,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.75
52 Week High
$7.94
$5.60

Technical Indicators

Market Signals
Indicator
ATXG
TIVC
Relative Strength Index (RSI) 43.87 69.31
Support Level $0.34 $0.79
Resistance Level $5.24 $2.70
Average True Range (ATR) 0.34 0.11
MACD -0.16 0.03
Stochastic Oscillator 9.49 100.00

Price Performance

Historical Comparison
ATXG
TIVC

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.

Share on Social Networks: